RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
  AIDS
  Anthrax
  Dengue
  Ebola
  HCV
  Influenza
  Leishmaniasis
  Malaria
  MRSA
  Mumps
  Pertussis
  Prion Diseases
  SARS
  Shigella
  Small Pox
  Tuberculosis
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Oct 11, 2012 - 10:22:56 PM
Tuberculosis Channel

subscribe to Tuberculosis newsletter
Latest Research : Infectious Diseases : Tuberculosis

   EMAIL   |   PRINT
Ipr1 Gene that influences Innate Immunity to Tuberculosis

Apr 14, 2005 - 4:21:00 PM
“Further studies of the Ipr1 gene in a mouse model and its counterpart in humans will improve our understanding of how our immune system works during complex interactions with live, and very successful, pathogens.”

 
[RxPG] Researchers from the Harvard School of Public Health studying tuberculosis resistance and susceptibility in animals have identified a gene in mice which plays a significant role in limiting the multiplication of intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes inside host cells. The gene, Intracellular pathogen resistance 1 (Ipr1), found in the chromosome location known as sst1 (super susceptibility to tuberculosis 1), turns on a regulated cell death pathway of the bacteria-infected cells causing apoptosis and prevents catastrophic cell death, or necrosis. The findings appear in a paper in the April 7, 2005 issue of the journal Nature.

It is estimated that 8 million people are infected with tuberculosis annually with approximately 2 million of those dying from the lung disease per year. Yet only about 10 percent of people infected actually develop tuberculosis. Stress, malnutrition and other environmental factors significantly influence an individuals’ susceptibility to developing the disease. In addition, genetic factors have been known to play an important role in determining outcomes of tuberculosis infection in human and other mammalian hosts. However, individual host resistance genes such as Ipr1, involved in innate immunity for tuberculosis, have been difficult to pinpoint, because of a highly complex multigenic control of host immunity.

The researchers studied which genes might influence an individuals’ susceptibility to developing tuberculosis and found that an important genetic determinant of host resistance to tuberculosis is encoded within the region on mouse chromosome 1, which they named sst1. By identifying the Ipr1 gene within the sst1 region they believe they have uncovered a new mechanism that helps in limiting the possibility of developing M. tuberculosis, especially in the lungs.

Of interest, the Ipr1 gene also controls innate immunity to another intracellular pathogen Listeria monocytogenes, a parasitic disease transferred to humans generally from consuming infected animal products and that causes flu-like symptoms, swelling of the brain and for pregnant women potential loss of fetus. That suggests that the Ipr1 gene controls a general mechanism that protects against other intracellular pathogens besides M. tuberculosis. The researchers suggest that the human equivalent of Ipr1 might be a gene described as SP110 and may play a significant role in determining tuberculosis susceptibility in people.

Igor Kramnik, assistant professor of immunology and infectious disease at the Harvard School of Public Health and senior author of the study said, “The findings are encouraging and highlight the role of genetic function in determining whether a person has a high risk of developing tuberculosis. Finding a specific gene in a mouse that has a human equivalent within a highly conserved genetic region suggests that the human equivalent may also be involved in innate immunity to the disease and may further lead to development of diagnostic tests and prevention approaches.” He added, “Further studies of the Ipr1 gene in a mouse model and its counterpart in humans will improve our understanding of how our immune system works during complex interactions with live, and very successful, pathogens.”



Publication: April 7, 2005 issue of the journal Nature
On the web: www.hsph.harvard.edu 

Advertise in this space for $10 per month. Contact us today.


Related Tuberculosis News
PA-824 : Promising new drug for TB
Drug resistent TB deadlier, more common than suspected
Diabetes mellitus increases risk of TB
XDR TB in South Africa traced to lack of drug susceptibility testing
Vitamin D supplements may offer cheap and effective immune system boost against TB
Tuberculin skin tests not sensitive in detecting latent TB
Emergence of highly drug-resistant tuberculosis strains requires urgent action
Treating populations infected with HIV and latent TB could speed the emergence of drug-resistant TB
Solution to TB epidemic may lie in protective Heme oxygenase 1 protein
Explaining Why People of African Descent Are More Vulnerable to TB

Subscribe to Tuberculosis Newsletter

Enter your email address:


 Additional information about the news article
The research was supported by grants from the National Institutes of Health.
 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)